These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 27504593)
1. Neurological, Metabolic, and Psychiatric Adverse Events in Children and Adolescents Treated With Aripiprazole. Jakobsen KD; Bruhn CH; Pagsberg AK; Fink-Jensen A; Nielsen J J Clin Psychopharmacol; 2016 Oct; 36(5):496-9. PubMed ID: 27504593 [TBL] [Abstract][Full Text] [Related]
2. Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder: a 12-week, open-label, preliminary study. Masi G; Gagliano A; Siracusano R; Berloffa S; Calarese T; Ilardo G; Pfanner C; Magazù A; Cedro C J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):120-5. PubMed ID: 22375853 [TBL] [Abstract][Full Text] [Related]
3. Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts. Budman C; Coffey BJ; Shechter R; Schrock M; Wieland N; Spirgel A; Simon E J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):509-15. PubMed ID: 18928415 [TBL] [Abstract][Full Text] [Related]
4. Adverse events in children and adolescents treated with quetiapine: an analysis of adverse drug reaction reports from the Danish Medicines Agency database. Jakobsen KD; Wallach-Kildemoes H; Bruhn CH; Hashemi N; Pagsberg AK; Fink-Jensen A; Nielsen J Int Clin Psychopharmacol; 2017 Mar; 32(2):103-106. PubMed ID: 27685179 [TBL] [Abstract][Full Text] [Related]
5. [Aripiprazole use in children and adolescent psychiatric patients]. Chevreuil C; Polard E; Lemonnier E; Guillemot P; Bentué-Ferrer D; Therapie; 2011; 66(2):123-30. PubMed ID: 21635859 [TBL] [Abstract][Full Text] [Related]
6. Aripiprazole in schizophrenia and schizoaffective disorder: A review. Stip E; Tourjman V Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550 [TBL] [Abstract][Full Text] [Related]
7. Open-label olanzapine treatment in five preadolescent children. Krishnamoorthy J; King BH J Child Adolesc Psychopharmacol; 1998; 8(2):107-13. PubMed ID: 9730076 [TBL] [Abstract][Full Text] [Related]
9. Epistaxis as an Unexpected Side Effect of Aripiprazole and Risperidone Treatment in Two Children with Two Different Psychiatric Diagnosis. Binici NC; Güney SA J Child Adolesc Psychopharmacol; 2017 Oct; 27(8):759-760. PubMed ID: 28665688 [No Abstract] [Full Text] [Related]
10. CLINICAL EXPERIENCE OF LONG-TERM TREATMENT WITH ARIPIPRAZOLE (ABILIFY) IN CHILDREN AND ADOLESCENTS AT THE CHILD AND ADOLESCENT PSYCHIATRIC CLINIC 1 IN ROSKILDE, DENMARK. Diomšina B; Rasmussen PD; Danilevičiütė V Acta Pol Pharm; 2015; 72(3):597-606. PubMed ID: 26642668 [TBL] [Abstract][Full Text] [Related]
11. Aripiprazole in Children and Adolescents. Coustals N; Ménard ML; Cohen D J Child Adolesc Psychopharmacol; 2021 Feb; 31(1):4-32. PubMed ID: 32931315 [No Abstract] [Full Text] [Related]
12. Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities. Valicenti-McDermott MR; Demb H J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):549-60. PubMed ID: 17069544 [TBL] [Abstract][Full Text] [Related]
13. No Differences in Weight Gain Between Risperidone and Aripiprazole in Children and Adolescents After 12 Months. Schoemakers RJ; van Kesteren C; van Rosmalen J; Eussen MLJM; Dieleman HG; Beex-Oosterhuis MM J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):192-196. PubMed ID: 30672720 [TBL] [Abstract][Full Text] [Related]
14. Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study. Lamberti M; Siracusano R; Italiano D; Alosi N; Cucinotta F; Di Rosa G; Germanò E; Spina E; Gagliano A Paediatr Drugs; 2016 Aug; 18(4):319-29. PubMed ID: 27278054 [TBL] [Abstract][Full Text] [Related]
15. [Acute Dystonia due to Aripiprazole Use in Two Children with Autism Spectrum Disorder in the First Five Years of Life]. Küçükköse M; Kabukçu Başay B Turk Psikiyatri Derg; 2017; 28(1):71-73. PubMed ID: 28291301 [TBL] [Abstract][Full Text] [Related]
16. Low-Dose Aripiprazole-Induced Nocturnal Enuresis in a 9-Year-Old Boy: A Case Report and the Possible Underlying Mechanism. Özdemir YE; Tanir Y Clin Neuropharmacol; 2021 May-Jun 01; 44(3):108-109. PubMed ID: 33811196 [TBL] [Abstract][Full Text] [Related]
17. Aripiprazole-Induced Hoarseness: A Case Report. Işik Ü; Çam Ray P Clin Neuropharmacol; 2019; 42(2):55-56. PubMed ID: 30724787 [TBL] [Abstract][Full Text] [Related]
18. Rhabdomyolysis reported for children and adolescents treated with antipsychotic medicines: a case series analysis. Star K; Iessa N; Almandil NB; Wilton L; Curran S; Edwards IR; Wong IC J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):440-51. PubMed ID: 23234587 [TBL] [Abstract][Full Text] [Related]
19. Aripiprazole Used to Treat Capgras Syndrome in an Adolescent Diagnosed With Autism. Baykal S; Mutlu C Clin Neuropharmacol; 2023 Mar-Apr 01; 46(2):85-86. PubMed ID: 36728844 [TBL] [Abstract][Full Text] [Related]
20. An open-label extension long-term study of the safety and efficacy of aripiprazole for irritability in children and adolescents with autistic disorder in Japan. Ichikawa H; Hiratani M; Yasuhara A; Tsujii N; Oshimo T; Ono H; Tadori Y Psychiatry Clin Neurosci; 2018 Feb; 72(2):84-94. PubMed ID: 28941259 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]